These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20555109)

  • 41. Comment on "lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival".
    Sprenger T; Rothe H; Langer C; Becker H; Liersch T
    Am J Surg Pathol; 2009 Jul; 33(7):1107; author reply 1108. PubMed ID: 19390426
    [No Abstract]   [Full Text] [Related]  

  • 42. An update on the multimodality of localized rectal cancer.
    Artac M; Korkmaz L; El-Rayes B; Philip PA
    Crit Rev Oncol Hematol; 2016 Dec; 108():23-32. PubMed ID: 27931837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pentheroudakis G; Orecchia R; Hoekstra HJ; Pavlidis N;
    Ann Oncol; 2010 May; 21 Suppl 5():v266-73. PubMed ID: 20555095
    [No Abstract]   [Full Text] [Related]  

  • 44. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Plataniotis G; Castiglione M;
    Ann Oncol; 2010 May; 21 Suppl 5():v41-5. PubMed ID: 20555100
    [No Abstract]   [Full Text] [Related]  

  • 45. Familial colorectal cancer risk: ESMO Clinical Practice Guidelines.
    Balmaña J; Castells A; Cervantes A;
    Ann Oncol; 2010 May; 21 Suppl 5():v78-81. PubMed ID: 20555108
    [No Abstract]   [Full Text] [Related]  

  • 46. Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
    Gérard JP; André T; Bibeau F; Conroy T; Legoux JL; Portier G; Bosset JF; Cadiot G; Bouché O; Bedenne L;
    Dig Liver Dis; 2017 Apr; 49(4):359-367. PubMed ID: 28179091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 48. Combined modality therapy of resectable rectal cancer: current approaches.
    Minsky BD
    Tech Coloproctol; 2004 Aug; 8(2):67-76. PubMed ID: 15309641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of image-guided radiotherapy for locally advanced rectal cancer.
    Nguyen NP; Ceizyk M; Almeida F; Chi A; Betz M; Modarresifar H; Sroka T; Cohen D; Jang S; Abraham D; Stevie M; Smith-Raymond L; Krafft S; Vinh-Hung V
    Ann Surg Oncol; 2011 Feb; 18(2):380-5. PubMed ID: 20848224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary: rectal cancer an evolution of treatment.
    Czito BG; Willett CG
    Oncologist; 2007 Nov; 12(11):1319-20. PubMed ID: 18055851
    [No Abstract]   [Full Text] [Related]  

  • 51. Rectal cancer multidisciplinary management: evidences and future landscape.
    Sebag-Montefiore D; Bujko K; Valentini V
    Radiother Oncol; 2009 Aug; 92(2):145-7. PubMed ID: 19596463
    [No Abstract]   [Full Text] [Related]  

  • 52. Primary malignant melanoma with surrounding melanosis in the anorectum.
    Kim J; Keum B; Seo YS; Kim YS; Jeen YT; Chun HJ; Um SH; Kim CD; Ryu HS
    Endoscopy; 2010; 42 Suppl 2():E47. PubMed ID: 20157885
    [No Abstract]   [Full Text] [Related]  

  • 53. Rectal cancer--clinical value of adjuvant and neoadjuvant treatment.
    Sjödahl R
    Kongressbd Dtsch Ges Chir Kongr; 2002; 119():149-52. PubMed ID: 12704879
    [No Abstract]   [Full Text] [Related]  

  • 54. Progress in rectal cancer staging and treatment.
    Pramateftakis MG; Kanellos D; Vrakas G; Tsachalis T; Raptis D; Makrantonakis A; Koukouritaki Z; Kanellos I
    Tech Coloproctol; 2010 Nov; 14 Suppl 1():S29-31. PubMed ID: 20686807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.
    Lutz MP; Zalcberg JR; Glynne-Jones R; Ruers T; Ducreux M; Arnold D; Aust D; Brown G; Bujko K; Cunningham C; Evrard S; Folprecht G; Gerard JP; Habr-Gama A; Haustermans K; Holm T; Kuhlmann KF; Lordick F; Mentha G; Moehler M; Nagtegaal ID; Pigazzi A; Pucciarelli S; Roth A; Rutten H; Schmoll HJ; Sorbye H; Van Cutsem E; Weitz J; Otto F
    Eur J Cancer; 2016 Aug; 63():11-24. PubMed ID: 27254838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer.
    Tveit KM; Kataja VV;
    Ann Oncol; 2005; 16 Suppl 1():i20-1. PubMed ID: 15888739
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of multimodality treatment in M0 rectal cancer: evidence and research.
    Valentini V; Barba MC; Gambacorta MA
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):334-41. PubMed ID: 20496544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenocarcinoma of rectosigmoid junction metastatic to testis.
    Rahman SU; Ali N; Ali M; Mansoor S; Mahmood T
    J Pak Med Assoc; 2003 Jan; 53(1):38-9. PubMed ID: 12666853
    [No Abstract]   [Full Text] [Related]  

  • 59. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Aebi S; Davidson T; Gruber G; Castiglione M;
    Ann Oncol; 2010 May; 21 Suppl 5():v9-14. PubMed ID: 20555111
    [No Abstract]   [Full Text] [Related]  

  • 60. Management of colorectal cancer.
    van de Velde CJ; Bloem RM; Zwaveling A
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):339-44. PubMed ID: 3519234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.